META vs VRT: Which Is the Better Buy?

Side-by-side comparison of Meta Platforms, Inc. and Vertiv Holdings Co β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-20.
Meta Platforms, Inc. Β· Communication Services
$646.01
+43.0% upside to fair value
High Conviction Grade A High Quality
VS
Vertiv Holdings Co Β· Industrials
$333.05
-45.0% upside to fair value
Grade D High Quality
QuantHub Verdict
META has more upside to fair value (+43.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric META VRT
Current Price $646.01 $333.05
Fair Value Estimate $924.09 $183.18
Upside to Fair Value +43.0% -45.0%
Market Cap $1,639.8B $127.9B
Forward P/E β€” 81.8x
EV / EBITDA 15.0x 55.4x
Price / Sales 7.6x 11.8x
Price / FCF 33.9x 55.4x
Revenue Growth YoY +33.1% +30.1%
Gross Margin 81.9% 36.2%
Operating Margin 41.2% 18.5%
Return on Equity 33.2% 42.1%
Dividend Yield 0.33% 0%
FCF Yield 2.95% 1.81%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
META β€” Meta Platforms, Inc.
Meta Platforms operates the Facebook, Instagram, Messenger and WhatsApp ecosystem and monetizes its 3.56 billion Family daily active people primarily through digital advertising. Business quality is high: the core platform combines global network effects, advertiser measurement data, creator supply, cross-app distribution and AI-driven ad ranking, supporting 81.9% gross margin, 41.2% operating ma…
VRT β€” Vertiv Holdings Co
Vertiv Holdings Co operates in the industrials sector, specializing in electrical equipment and parts with a strong focus on data center critical infrastructure. The company benefits from a durable competitive position supported by a broad product portfolio that drives approximately 75% of sales from data centers. Vertiv's business quality is high, demonstrated by a 42.1% return on equity, strong…
Accumulation Zones
Metric META VRT
Zone Low $693.07 $137.38
Zone High $785.48 $155.70
In Buy Zone? Yes No
← META Research    VRT Research β†’    All Research